Hillstream Biopharma Performance
| HILSDelisted Stock | USD 0.39 0.01 2.50% |
The company retains a Market Volatility (i.e., Beta) of -3.03, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Hillstream Biopharma are expected to decrease by larger amounts. On the other hand, during market turmoil, Hillstream Biopharma is expected to outperform it. Hillstream Biopharma right now retains a risk of 0.0%. Please check out Hillstream Biopharma potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Hillstream Biopharma will be following its current trending patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Hillstream Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Hillstream Biopharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 4356.00 |
Hillstream |
Hillstream Biopharma Relative Risk vs. Return Landscape
If you would invest 39.00 in Hillstream Biopharma on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Hillstream Biopharma or generate 0.0% return on investment over 90 days. Hillstream Biopharma is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Hillstream, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Hillstream Biopharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hillstream Biopharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Hillstream Biopharma, and traders can use it to determine the average amount a Hillstream Biopharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| HILS |
Based on monthly moving average Hillstream Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hillstream Biopharma by adding Hillstream Biopharma to a well-diversified portfolio.
Hillstream Biopharma Fundamentals Growth
Hillstream Stock prices reflect investors' perceptions of the future prospects and financial health of Hillstream Biopharma, and Hillstream Biopharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hillstream Stock performance.
| Return On Equity | -1.47 | |||
| Return On Asset | -0.78 | |||
| Current Valuation | 496.66 K | |||
| Shares Outstanding | 17.53 M | |||
| Price To Book | 0.88 X | |||
| EBITDA | (6.88 M) | |||
| Cash And Equivalents | 9.48 M | |||
| Cash Per Share | 0.82 X | |||
| Total Debt | 772.9 K | |||
| Book Value Per Share | 0.18 X | |||
| Cash Flow From Operations | (6.56 M) | |||
| Earnings Per Share | (0.76) X | |||
| Total Asset | 6.69 M | |||
| Retained Earnings | (15.38 M) | |||
About Hillstream Biopharma Performance
Assessing Hillstream Biopharma's fundamental ratios provides investors with valuable insights into Hillstream Biopharma's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Hillstream Biopharma is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death for the treatment resistant cancers. The company was incorporated in 2017 and is based in Bridgewater, New Jersey. Hillstream Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1 people.Things to note about Hillstream Biopharma performance evaluation
Checking the ongoing alerts about Hillstream Biopharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hillstream Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hillstream Biopharma is not yet fully synchronised with the market data | |
| Hillstream Biopharma has some characteristics of a very speculative penny stock | |
| Hillstream Biopharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (8.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hillstream Biopharma currently holds about 9.48 M in cash with (6.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.82, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 39.0% of the company shares are held by company insiders |
- Analyzing Hillstream Biopharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hillstream Biopharma's stock is overvalued or undervalued compared to its peers.
- Examining Hillstream Biopharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hillstream Biopharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hillstream Biopharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hillstream Biopharma's stock. These opinions can provide insight into Hillstream Biopharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Hillstream Stock
If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |